Argatroban - HikmaAlternative Names: Argatroban injection; Injectable argatroban
Latest Information Update: 17 Dec 2012
At a glance
- Originator Hikma Pharmaceuticals
- Class Antithrombotics; Pipecolic acids; Small molecules
- Mechanism of Action Thrombin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Heparin-induced thrombocytopenia and thrombosis syndrome